USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.21 | $-0.19 | $-0.32 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | $3.00M | $0.00 |
Calithera Biosciences's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-0.18 | $-0.27 | $-0.10 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-0.86 | $-1.00 | $-0.69 |
| Dec 2022 | 5 | $-0.82 | $-1.65 | $-0.44 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.18 | $-0.18 | $-0.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.86 | $-0.86 | $-0.94 |
| Dec 2022 | 0 / 0 | $-0.82 | $-0.82 | $-0.87 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $3.00M | $3.00M | $3.00M |
| Dec 2022 | 5 | $1.00M | $0.00 | $5.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.21 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.23 | $-0.19 | 18.91% |
| May 6, 2021 | Mar 2021 | $-0.26 | $-0.28 | -8.15% |
| Mar 16, 2021 | Dec 2020 | $-0.33 | $-0.32 | 2.08% |
| Nov 5, 2020 | Sep 2020 | $-0.31 | $-0.32 | -1.72% |
| Aug 10, 2020 | Jun 2020 | $-0.33 | $-0.29 | 12.01% |
| May 7, 2020 | Mar 2020 | $-0.36 | $-0.38 | -5.76% |
| Mar 11, 2020 | Dec 2019 | $-0.37 | $-0.39 | -4.84% |
| Nov 12, 2019 | Sep 2019 | $-0.45 | $-0.38 | 14.89% |
| Aug 8, 2019 | Jun 2019 | $-0.56 | $-0.58 | -4.35% |
| May 9, 2019 | Mar 2019 | $-0.44 | $-0.61 | -37.20% |
| Mar 7, 2019 | Dec 2018 | $-0.47 | $-0.51 | -7.87% |
| Nov 7, 2018 | Sep 2018 | $-0.40 | $-0.52 | -30.46% |
| Aug 7, 2018 | Jun 2018 | $-0.32 | $-0.09 | 71.87% |
| May 10, 2018 | Mar 2018 | $-0.32 | $-0.37 | -14.27% |
| Mar 8, 2018 | Dec 2017 | $-0.22 | $-0.31 | -41.36% |
| Nov 2, 2017 | Sep 2017 | $-0.22 | $-0.17 | 21.70% |
| Aug 8, 2017 | Jun 2017 | $-0.22 | $-0.15 | 31.35% |
| May 9, 2017 | Mar 2017 | $-0.29 | $-0.22 | 23.77% |
| Mar 16, 2017 | Dec 2016 | $-0.46 | $-0.45 | 1.96% |
| Nov 9, 2016 | Sep 2016 | $-0.52 | $-0.44 | 15.21% |
| Aug 9, 2016 | Jun 2016 | $-0.52 | $-0.55 | -5.77% |
| May 10, 2016 | Mar 2016 | $-0.47 | $-0.52 | -9.87% |
| Mar 15, 2016 | Dec 2015 | $-0.56 | $-0.44 | 21.43% |
| Nov 9, 2015 | Sep 2015 | $-0.52 | $-0.49 | 5.77% |
| Aug 10, 2015 | Jun 2015 | $-0.44 | $-0.44 | - |
| May 7, 2015 | Mar 2015 | $-0.47 | $-0.44 | 6.38% |
| Mar 26, 2015 | Dec 2014 | $-0.47 | $-0.39 | 17.02% |
| Nov 14, 2014 | Sep 2014 | $-0.35 | $-16.85 | -4714.29% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $-1.31 | $-1.31 | - |
| Mar 11, 2020 | Dec 2019 | $-1.88 | $-1.96 | - |
| Mar 7, 2019 | Dec 2018 | $-1.46 | $-1.49 | - |
| Mar 8, 2018 | Dec 2017 | $-0.75 | $-0.85 | - |
| Mar 16, 2017 | Dec 2016 | - | $-1.96 | - |
| Mar 15, 2016 | Dec 2015 | - | $-1.81 | - |
| Mar 26, 2015 | Dec 2014 | - | $-17.24 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 5, 2021 | Jun 2021 | $0.00 | $3.00M | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $600.00K | $0.00 | - |
| Nov 5, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 10, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 7, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 11, 2020 | Dec 2019 | $2.50M | $0.00 | - |
| Nov 12, 2019 | Sep 2019 | $2.00M | $0.00 | - |
| Aug 8, 2019 | Jun 2019 | $2.00M | $0.00 | - |
| May 9, 2019 | Mar 2019 | $4.33M | $0.00 | - |
| Mar 7, 2019 | Dec 2018 | $1.73M | $22.25M | 12.86% |
| Nov 7, 2018 | Sep 2018 | $4.85M | $17.07M | 3.52% |
| Aug 7, 2018 | Jun 2018 | $6.13M | $17.07M | 2.78% |
| May 10, 2018 | Mar 2018 | $7.19M | $5.19M | 0.72% |
| Mar 8, 2018 | Dec 2017 | $5.46M | $7.25M | 1.33% |
| Nov 2, 2017 | Sep 2017 | $4.51M | $7.25M | 1.61% |
| Aug 8, 2017 | Jun 2017 | $10.50M | $7.25M | 0.69% |
| May 9, 2017 | Mar 2017 | - | $4.19M | - |
| Mar 16, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 9, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 9, 2016 | Jun 2016 | - | $0.00 | - |
| May 10, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 15, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $50.00K | - |
| Aug 10, 2015 | Jun 2015 | - | $56.00K | - |
| May 7, 2015 | Mar 2015 | - | $9.00K | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 14, 2014 | Sep 2014 | - | $2.00K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $480.00K | $0.00 | - |
| Mar 11, 2020 | Dec 2019 | $2.50M | $0.00 | - |
| Mar 7, 2019 | Dec 2018 | $23.96M | $22.25M | -7.12% |
| Mar 8, 2018 | Dec 2017 | $24.24M | $25.95M | 7.08% |
| Mar 16, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 15, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $9.00K | - |
CALA's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 5 analysts, the average EPS estimation for Calithera Biosciences's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.26, and a high estimation of $-0.14.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.21, and the 3 month trend is $-0.23.
Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Calithera Biosciences's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
CALA's earnings per share (EPS) was $-0.19, beating the consensus analysts forecast of $-0.23 by 18.91%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -32.14%, and higher than the same period a year before (Jun 2020) by -34.48%.
Revenues were $3.00M.
The company reported a net income of $-14.31M.Free cash flow for the quarter was $-11.12M , compared to $-22.00M last quarter and $-18.00M a year before.
CALA ended the quarter with $3.67M in total debt, a decrease of -2.03% compared to the previous quarter, and a decrease of -50.28% compared to the same quarter a year before.
Calithera Biosciences's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.
CALA's earnings per share (EPS) was $-1.31, beating the consensus analysts forecast of $-1.31 by 0.00% , and higher than the previous year's EPS (Dec 2019) by -33.16%.
Revenues were $0.00.
The company reported a net income of $-90.14M.
Calithera Biosciences reported a free cash flow of $-84.37M for its fiscal year, compared to $-78.75M a year ago.
The company ended the fiscal year with $6.72M in total debt, a decrease of -18.03% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
